MYRIAD GENETICS INC (MYGN) Stock Income Statement
USA - NASDAQ:MYGN - US62855J1043 - Common Stock
8.05 USD
+0.19 (+2.42%)
8.05 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 832.90M | 837.60M | 753.20M | 678.40M | 690.60M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Cost Of Goods | 246.70M | 252.20M | 236.20M | 202.00M | 197.60M | |||
| Gross Profit | 586.70M | 585.40M | 517.00M | 476.40M | 493.00M | |||
| Operating Expenses | 662.50M | 673.40M | 653.90M | 600.10M | 619.70M | |||
| Research and Development | 113.80M | 113.40M | 88.70M | 85.40M | 81.90M | |||
| Selling, General, and Administrative Expenses | 549.40M | 560.00M | 565.20M | 514.70M | 537.80M | |||
| Operating Income | -76.60M | -88.00M | -136.90M | -123.70M | -126.70M | |||
| Interest Income/Expense | -2.60M | -1.10M | -400.00K | -600.00K | -5.90M | |||
| Other Income/Expense | -500.00K | -1.10M | -4.40M | 600.00K | -600.00K | |||
| Non Recurring Items | N/A | -33.30M | -120.50M | -16.90M | 76.70M | |||
| Income Before Taxes | -420.10M | -123.50M | -262.20M | -140.60M | -57.10M | |||
| Income Tax | -25.10M | 3.80M | 1.10M | -28.60M | -32.60M | |||
| Net Income | -395.10M | -127.30M | -263.30M | -112.00M | -27.20M | |||
| EBITDA | -17.90M | -26.80M | -75.00M | -71.00M | -63.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.28 | -1.41 | -3.18 | -1.39 | -0.34 | |||
| Non GAAP EPS | 0.11 | 0.13 | -0.28 | -0.30 | 0.02 | |||
| Statistics | ||||||||
| Gross Profit Margin | 70.44% | 69.89% | 68.64% | 70.22% | 71.39% | |||
| Profit Margin | -47.44% | -15.20% | -34.96% | -16.51% | -3.94% | |||
| Operating Profit Margin | -9.20% | -10.51% | -18.18% | -18.23% | -18.35% | |||
All data in USD